首页> 外国专利> METHOD FOR THE REMOVAL OF UNDESIRED CELLS FROM HUMAN LYMPHOCYTE POPULATIONS, APPLICATION OF THE METHOD IN MONOCLONAL ANTIBODY PRODUCTION AND KIT THEREFOR.

METHOD FOR THE REMOVAL OF UNDESIRED CELLS FROM HUMAN LYMPHOCYTE POPULATIONS, APPLICATION OF THE METHOD IN MONOCLONAL ANTIBODY PRODUCTION AND KIT THEREFOR.

机译:从人淋巴细胞群体中去除不需要的细胞的方法,该方法在单克隆抗体生产及其套件中的应用。

摘要

in a process for the in vitro immunization and used to eliminate unwanted cells in populations of cells with human lymphocytes, agents are used which are required to be lysosomotropes in vitro cell populations containing cells cytes humans.a method is also described for the in vitro immunization of lymphocytes for use in the production of human monoclonal antibodies.in this process, lysosomotropes agents are called to act in vitro on human lymphocyte containing cell populations from, in order to enable the removal of cell populations with a negative effect on the in vitro immunization, lymphocytes were immunized. according to the specific antigen in vitro and immortalized.a kit used in the immunization of lymphocytes in vitro and used for the production of human monoclonal antibodies is also described. it contains as active component and a container of a container of lymphokines lysosomotropes agents.
机译:在用于体外免疫的方法中,并用于消除具有人类淋巴细胞的细胞群中的有害细胞,所使用的试剂在含有人细胞的体外细胞群体中需要是溶溶同养性的。还描述了一种用于体外免疫的方法用于生产人单克隆抗体的淋巴细胞。在此过程中,溶菌素试剂被称为在体外对含人淋巴细胞的细胞群产生体外作用,以便能够去除对体外免疫产生负面影响的细胞群免疫淋巴细胞。根据体外特异性抗原并永生化。还描述了用于体外免疫接种淋巴细胞和用于产生人单克隆抗体的试剂盒。它含有作为活性成分的容器和一个容器的溶血亲溶性淋巴因子药剂。

著录项

  • 公开/公告号EP0342188A1

    专利类型

  • 公开/公告日1989-09-13

    原文格式PDF

  • 申请/专利权人 BIOINVENT INTERNATIONAL AB;

    申请/专利号EP19870906018

  • 申请日1987-09-01

  • 分类号C12N5/10;C12N5/00;C12N5/16;C12N15/02;C12N15/09;C12P21/02;C12P21/08;

  • 国家 EP

  • 入库时间 2022-08-22 06:33:44

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号